exRNAdisease

Entry Detail

General Information

Database ID:

exR0356429

RNA Name:

hsa-miR-151a-3p

RNA Type:

miRNA

Chromosome:

chr8

Starnd:

-

Coordinate:

Start Site(bp):

140732587

End Site(bp):

140732607

External Links:

hsa-miR-151a-3p

Disease Information

Disease Name:	Breast Cancer
Disease Category:	Cancers
MeSH ID:	D001943
Type:	Neoplasms/Breast Neoplasms
Alias:	Breast Neoplasms//Breast Neoplasm//Neoplasm, Breast//Breast Tumors//Breast Tumor//Tumor, Breast//Tumors, Breast//Neoplasms, Breast//Breast Cancer//Cancer, Breast//Mammary Cancer//Cancer, Mammary//Cancers, Mammary//Mammary Cancers//Malignant Neoplasm of Breast//Breast Malignant Neoplasm//Breast Malignant Neoplasms//Malignant Tumor of Breast//Breast Malignant Tumor//Breast Malignant Tumors//Cancer of Breast//Cancer of the Breast//Mammary Carcinoma, Human//Carcinoma, Human Mammary//Carcinomas, Human Mammary//Human Mammary Carcinomas//Mammary Carcinomas, Human//Human Mammary Carcinoma//Mammary Neoplasms, Human//Human Mammary Neoplasm//Human Mammary Neoplasms//Neoplasm, Human Mammary//Neoplasms, Human Mammary//Mammary Neoplasm, Human//Breast Carcinoma//Breast Carcinomas//Carcinoma, Breast//Carcinomas, Breast

Expression Detail

GEO ID:	GSE98181
Description:	Circulating miRNA profiles from serum of women at high-risk for breast cancer
Experimental Design:	Cancer vs Control
Case Disease Type:	Breast Cancer
Case Disease SubType:	NA
Case Sample:	Breast Cancer
Control Sample:	Healthy
Number of Case:	24
Number of Control:	24
Number of Samples:	48

Regulatory Relationship

mRNA targets:

Gene Symbol	Chromosome	Start Site(bp)	End Site(bp)	Strand
ACP1	chr2	264140	278283	+
PCDHA1	chr5	140786136	141012347	+
PCDHA10	chr5	140855883	141012347	+
PCDHA11	chr5	140868183	141012344	+
PCDHA12	chr5	140875302	141012347	+
PCDHA13	chr5	140882124	141012347	+
PCDHA2	chr5	140794852	141012347	+
PCDHA3	chr5	140801028	141012347	+
PCDHA4	chr5	140806929	141012347	+
PCDHA5	chr5	140821604	141012347	+
PCDHA6	chr5	140827958	141012347	+
PCDHA7	chr5	140834248	141012347	+
PCDHA8	chr5	140841187	141012347	+
PCDHA9	chr5	140847463	141012344	+
PCDHAC1	chr5	140926369	141012344	+
PCDHAC2	chr5	140966470	141012347	+
STRBP	chr9	123109500	123268586	-

miRNA targets:

NA

circRNA targets:

NA

lncRNA targets:

lncRNA Symbol	Chromosome	Start Site(bp)	End Site(bp)	Strand
AC044784.1	chr10	8970125	8973468	+
AC104794.2	chr2	10083781	10086101	+
AL160006.1	chr1	110058340	110062555	+
SCARNA9	chr11	93721513	93721865	+
TUG1	chr22	30969245	30979395	+

Display:

Experiment Detail

GEO ID:	GSE98181
Sample Source:	Blood
Source Fraction:	Serum
Platform:	GPL21572
Method:	Microarray
Num of detected RNA Type:	1
Num of detected RNAs of this Type:	2546
Sample treatment protocol:	Serum is obtained from coagulated whole blood samples by centrifugation at 3000 rpm for 10 minutes.
RNA Extract protocol:	RNA was isolated from a 200ul serum aliquot using the miRNeasy Serum Plasma kit with ce-miR-39 spike-in (QIAGEN), QIAcube (QIAGEN) automation, and eluted with 14uL of nuclease-free water.
RNA library preparation protocol:	Exactly 8ul of RNA was tagged with a Poly-A tail, using an ATP driven reaction from the Affymetrix® FlashTag™ Biotin HSR RNA Labeling Kit.

Reference

PMID:	29348816
Title:	Development of a predictive miRNA signature for breast cancer risk among high-risk women.
Author:	Farina NH, Ramsey JE, Cuke ME, Ahern TP, Shirley DJ, Stein JL, Stein GS, Lian JB, Wood ME
Journal:	Oncotarget. 2017 Nov 28;8(68):112170-112183.
Description:	We evaluated the ability of C-miRNAs to identify women most likely to develop breast cancer by profiling miRNA from serum obtained long before diagnosis.